-
The contribution of GTF2I haploinsufficiency to Williams syndrome
- Back
Metadata
Document Title
The contribution of GTF2I haploinsufficiency to Williams syndrome
Author
Chailangkarn T, Noree C, Muotri AR
Name from Authors Collection
Affiliations
National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego
Type
Article; Proceedings Paper
Source Title
MOLECULAR AND CELLULAR PROBES
Year
2018
Volume
40
Page
45-51
Open Access
Green Accepted
Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI
10.1016/j.mcp.2017.12.005
Format
Abstract
Williams syndrome (WS) is a neurodevelopmental disorder involving hemideletion of as many as 26-28 genes, resulting in a constellation of unique physical, cognitive and behavior phenotypes. The haploinsufficiency effect of each gene has been studied and correlated with phenotype(s) using several models including WS subjects, animal models, and peripheral cell lines. However, links for most of the genes to WS phenotypes remains unclear. Among those genes, general transcription factor 21 (GTP2I) is of particular interest as its haploinsufficiency is possibly associated with hypersociability in WS. Here, we describe studies of atypical WS cases as well as mouse models focusing on GTF2I that support a role for this protein in the neurocognitive and behavioral profiles of WS individuals. We also review collective studies on diverse molecular functions of GTF2I that may provide mechanistic explanation for phenotypes recently reported in our relevant cellular model, namely WS induced pluripotent stem cell (iPSC)-derived neurons. Finally, in light of the progress in gene-manipulating approaches, we suggest their uses in revealing the neural functions of GTF2I in the context of WS.
Keyword
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
Funding Sponsor
California Institute for Regenerative Medicine (CIRM) [TR4-06747]; National Institutes of Health [P01 NICHD033113, 156MH109587, U19MH107367]; NARSAD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD033113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109885, R56MH109587, U19MH107367, R01MH108528] Funding Source: NIH RePORTER
License
Copyright
Rights
Elsevier Ltd.
Publication Source
WOS